Instructions for Codelac Broncho with thyme (Ambroxol)
English product name
Codelac Broncho with thymus serpyllum
Release form
Elixir
Description:
Elixir from light brown to brown; during storage, the formation of sediment is allowed.
5 ml
ambroxol hydrochloride 10 mg
sodium glycyrrhizate 30 mg
liquid thyme extract 500 mg
Auxiliary substances: methylparahydroxybenzoate (nipagin) - 3.75 mg, propyl parahydroxybenzoate (nipazol) - 1.25 mg, sorbitol (sorbitol) - 3000 mg, water purified - up to 5 ml.
ATC codes
R05CA10 Combination drugs Codelac Broncho
Clinical-pharmacological groups / Group affiliation
Preparation with mucolytic, expectorant and anti-inflammatory action
Active substance
ambroxol hydrochloride
sodium glycyrrhizate
liquid thyme extract
Pharmacotherapy group
Expectorant combined agent
Storage Conditions
The drug Codelac Broncho should be stored in a place inaccessible to children, protected from light at a temperature not higher than 25 ° C.
Best before date
Shelf life - one and a half years
Testimony Codelac Broncho:
- Diseases of the respiratory tract with formation of viscous sputum:
- acute and chronic bronchitis;
- pneumonia;
- COPD;
- bronchiectasis.
Method of use, course and dosage:
They are taken in during meals, with a small amount of water.
Adults and children over twelve years old - ten ml four times a day
Children aged two to six years are given 2.5 ml three times a day, and those aged six to twelve years five ml three times a day.
The maximum duration of treatment without a doctor's consultation is five days.
Application for kidney disorders
Use the drug Codelac Broncho with caution in patients with kidney failure.
Use in liver disorders
Use with caution in patients with liver failure.
Terms of Sale
The drug is allowed to be used as a non-prescription drug Codelac Broncho.
Use in children
Use in children under 2 years of age is contraindicated.
- Nosology (ICD codes)
- J15
- Bacterial pneumonia not classified elsewhere
- J20
- Acute bronchitis
- J42
- Chronic bronchitis unspecified
- J44
- Other chronic obstructive pulmonary disease
Pharmacological effect:
Combined expectorant preparation. It has a mucolytic and expectorant effect, as well as anti-inflammatory activity. The effect of the elixir Kodelak® Bronho with thyme is due to the pharmacological properties of its components.
Ambroxol has a secretomotor, secretolytic and expectorant effect, normalizes the broken ratio of sulfur and mucous components of sputum, increases surfactant secretion in the alveoli. Reduces the viscosity of the sputum and promotes its withdrawal.
Sodium glycyrrhizate has an anti-inflammatory and antiviral effect. It has a cytoprotective effect due to antioxidant and membrane stabilizing activity. Enhances the action of endogenous glucocorticoids, having an anti-inflammatory and anti-allergic effect. Due to the pronounced anti-inflammatory activity, it helps to reduce the inflammatory process in the respiratory tract.
The extract from the chabreca herb contains a mixture of essential oils with expectorant and anti-inflammatory effects. In addition, this extract has weak spasmolytic and reparative properties.
